dicarbethoxydihydrocollidine and Cirrhoses, Experimental Liver

dicarbethoxydihydrocollidine has been researched along with Cirrhoses, Experimental Liver in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fragoulis, A; Herzog, M; Jahr, H; Kensler, TW; Pufe, T; Schellenberg, T; Schenkel, J; Streetz, KL; Trautwein, C; Wruck, CJ	1

Other Studies

1 other study(ies) available for dicarbethoxydihydrocollidine and Cirrhoses, Experimental Liver

Article	Year
Nrf2 Ameliorates DDC-Induced Sclerosing Cholangitis and Biliary Fibrosis and Improves the Regenerative Capacity of the Liver. Toxicological sciences : an official journal of the Society of Toxicology, 2019, 06-01, Volume: 169, Issue:2 Topics: Animals; Bilirubin; Cholangitis, Sclerosing; Kelch-Like ECH-Associated Protein 1; Liver Cirrhosis, Experimental; Liver Regeneration; Mice; NF-E2-Related Factor 2; Porphyrins; Pyridines; Signal Transduction	2019

Article

Year

Nrf2 Ameliorates DDC-Induced Sclerosing Cholangitis and Biliary Fibrosis and Improves the Regenerative Capacity of the Liver.

Toxicological sciences : an official journal of the Society of Toxicology, 2019, 06-01, Volume: 169, Issue:2

Topics: Animals; Bilirubin; Cholangitis, Sclerosing; Kelch-Like ECH-Associated Protein 1; Liver Cirrhosis, Experimental; Liver Regeneration; Mice; NF-E2-Related Factor 2; Porphyrins; Pyridines; Signal Transduction

2019